Wellgistics Health Inc Surge: Wellgistics Health Inc (WGRX) saw its stock price soar over 200% following a collaboration announcement with Datavault AI Inc (DVLT) to integrate blockchain technology into pharmaceutical logistics, attracting significant attention from investors and ETFs focused on AI and healthcare.
Convergence of Technologies: The partnership aligns with a growing trend of merging AI, blockchain, and healthcare innovation, with thematic ETFs like ARK Genomic Revolution ETF and ROBO Global Healthcare Technology and Innovation ETF already capitalizing on this convergence.
PharmacyChain Platform: The collaboration aims to develop the PharmacyChain platform, which will enhance transparency in drug tracking and address longstanding issues in pharmacy logistics, while also exploring a revenue-sharing model for platform usage.
Technological Advancements: This initiative follows Wellgistics' launch of HubRx AI, its proprietary AI platform for pharmacy operations, indicating a strong commitment to leveraging technology for improved efficiency in the healthcare supply chain.
Wall Street analysts forecast DVLT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DVLT is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast DVLT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DVLT is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.897
Low
4.00
Averages
4.00
High
4.00
Current: 0.897
Low
4.00
Averages
4.00
High
4.00
Maxim
NULL -> Buy
maintain
$3 -> $4
2026-01-05
Reason
Maxim
Price Target
$3 -> $4
AI Analysis
2026-01-05
maintain
NULL -> Buy
Reason
Maxim raised the firm's price target on Datavault to $4 from $3 and keeps a Buy rating on the shares. Following the WiSA merger and the strategic acquisition of CSI, along with new licensing deals and a $150M Bitcoin infusion from Scilex, the company's IP portfolio across Web 3.0, audio technologies, and data monetization is increasingly promising, the analyst tells investors in a research note.
Maxim
Maxim
Hold
to
Buy
upgrade
$3
2025-06-12
Reason
Maxim
Maxim
Price Target
$3
2025-06-12
upgrade
Hold
to
Buy
Reason
Maxim upgraded Datavault to Buy from Hold with a $3 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DVLT
Unlock Now
About DVLT
Datavault AI Inc. is a data licensing and monetization company. The Company’s patented platform enables secure data valuation, exchange, and AI-driven monetization-enabling businesses and creators to unlock the value of their data assets across cloud, Web 3.0, and experiential computing landscapes. Its offerings are its artificial intelligence (AI)-driven agents branded as Data Vault, DataValue, DataScore, and Data Vault Bank. These tools harness generative AI to deliver enterprise-grade data management solutions. It operates through two synergistic platforms: Data Science and Acoustic Science. Its Data Sciences Platform is anchored by its flagship Data Vault platform, a patented, cyber-secured asset tokenization platform that sets a new standard for trust and innovation in Web 3.0 data science. The Acoustic Sciences Platform features a fusion of WiSA’s wireless standard technology and the category creating ADIO inaudible tone, data over sound, and mobile quick response technology.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
